Mr. Jean-paul Cloze
Pharmacology and Physiology
Actelion
Switzerland
Biography
Mr. Jean-Paul Clozel, M.D., co- founded Actelion Ltd (alternate name Actelion AG ) in 1997 and has been its Chief Executive Officer since 1999. Mr. Clozel serves as the Chief Executive Officer of Idorsia Ltd, a wholly-owned subsidiary of Actelion Ltd. He was a Practicing Cardiologist for 11 years, from 1974 to 1985. He served as the Head of Drug Discovery Group in the Cardiovascular Department of F. Hoffmann-La Roche for 12 years, from 1985 to 1997. He serves as a Director of Actelion Pharmaceuticals Ltd. and Idorsia Ltd. He served as a Director of Actelion Ltd until June 16, 2017. He served as a Professor to the Chairman of Technical Innovation - Liliane Bettencourt at College de France, Paris, France for one year. Mr. Clozel holds a Medical Degree in France and obtained further training in Pharmacology and Physiology at the University of Montreal, Canada and the University of California, San Francisco.
Research Interest
Pharmacology and Physiology